Sign In
Buy GMED
$77.95
-0.300 (-0.383%)
At Close: Jun 03, 2026
Global Surgical Gloves (Latex, Neoprene, Polyisoprene, Nitrile, Others) Market Assessment 2015-2025 - ResearchAndMarkets.com
12:00am, Thursday, 14'th May 2020
The
The Rohatyn Group schließt Investition in europäische Auftragsforschungsorganisation Optimapharm ab
12:00am, Tuesday, 12'th May 2020
Wie The Rohatyn Group („TRG“), eine auf Schwellenländer fokussierte Vermögensverwaltungsfirma, heute bekanntgab, tätigte die Gruppe eine Investition i
OL: Matthias Kyburz über Militär-Spiele als Corona-Schleuder - Blick
01:32pm, Monday, 11'th May 2020
In Italien sind sich die Sportler sicher: Sie haben sich schon im Oktober an den Militär-Weltspielen in Wuhan mit dem Coronavirus angesteckt. Das Schweizer Team blieb aber verschont.
Forschung – Das braucht es für den Corona-Impfstoff - Blick
01:48pm, Sunday, 10'th May 2020
Die globale Kooperation zur Erforschung eines wirksamen Impfstoffes gegen Covid-19 ist beispiellos. Experten mahnen zur Geduld, Forscherteams rund um die Welt wollen aber noch in diesem Jahr ein Präp
Globus Medical, Inc. (GMED) CEO Dave Demski on Q1 2020 Results - Earnings Call Transcript
03:34am, Sunday, 10'th May 2020
Globus Medical, Inc. (NYSE:GMED) Q1 2020 Earnings Conference Call May 07, 2020 04:30 PM ET Company Participants Brian Kearns - Senior VP of Investor Relations D
Analysts Are Much More Bearish On Globus Medical, Inc. (NYSE:GMED) Than They Used To Be
01:34pm, Saturday, 09'th May 2020
The analysts covering Globus Medical, Inc. (NYSE:GMED) delivered a dose of negativity to shareholders today, by making...
Globus Medical Inc (GMED) Q1 2020 Earnings Call Transcript
01:30am, Saturday, 09'th May 2020
Ladies and gentlemen, thank you for standing by and welcome to Globus Medical's First Quarter 2020 Earnings conference call. Thank you, I'll now turn the call over to Mr. Brian Kearns, Senior VP of I
UBS Maintains Buy on Globus Medical, Lowers Price Target to $61
06:06pm, Friday, 08'th May 2020Credit Suisse Maintains Outperform on Globus Medical, Raises Price Target to $57
02:30pm, Friday, 08'th May 2020Globus Medical (GMED) Misses on Q1 Earnings and Revenues
02:23pm, Friday, 08'th May 2020
Globus Medical (GMED) witnesses around $20 million of COVID-19 related adverse impact on its Q1 sales.
Morgan Stanley Maintains Equal-Weight on Globus Medical, Raises Price Target to $52
12:29pm, Friday, 08'th May 2020U.S. RESEARCH ROUNDUP-Becton Dickinson, Epam Systems, PayPal Holdings
11:36am, Friday, 08'th May 2020
Wall Street securities analysts on Friday revised their ratings and price targets on several
U.S.-listed companies, including Becton Dickinson, Epam Systems and PayPal Holdings.
HIGHLIGHTS
Why Globus Medical Missed Q1 Estimates
11:00am, Friday, 08'th May 2020
Yes, it's been a rough year for Globus Medical (NYSE: GMED). Globus announced its first-quarter results after the market closed on Thursday. Globus Medical reported first-quarter revenue of $190.6
